BridgeBio Pharma, Inc.
- Targets
- 1
- Filings
- 1
- Median premium
- 41%
- First filing
- Dec 15, 2020
- Latest filing
- Dec 15, 2020
Targets
| Company | Score before deal | Score now | Filings | Latest |
|---|---|---|---|---|
| Eidos Therapeutics, Inc. | — | — | 1 | Dec 15, 2020 |
Deal filings
| Filed | Company | Form | Price | Premium |
|---|---|---|---|---|
| Dec 15, 2020 | Eidos Therapeutics, Inc. | DEFM14A | $1.85 | 41% |